CBD Knee Osteoarthritis Study

Part of paid clinical trials in Memphis, Tennessee.

Sponsor
University of Tennessee
Study ID
NCT07638189
Phase
PHASE2
Status
Not Yet Recruiting

Notify me when recruiting opens

Save your spot on the interest list for this study. We'll keep your details with this study so our team can follow up when recruiting opens.

Not yet recruiting

Add your contact details and location so we can keep your interest tied to this study.

Conditions

  • Osteoarthitis

Eligibility Criteria

Sex
ALL
Age
21 Years - N/A
Healthy Volunteers
Not accepted

Interventions

  • Cannabidiol (CBD) — DIETARY_SUPPLEMENT
    250 mg of CBD will be dissolved in 1 ml of Castor Oil. Participants will use 1ml of this solution on each knee BID
  • Castor Oil (Placebo) — OTHER
    1 ml of Castor oil alone will be applied to each knee BID as the placebo

Study Details

Osteoarthritis of the knee is a common cause of pain in the US. The currently available medicines for knee osteoarthritis sometimes are not effective at relieving the pain or have unacceptable side effects. Thus, alternate pain relieving treatments are needed. CBD, an active chemical from the hemp derived cannabis sativa plant, has received a lot of attention for its potential pain relieving properties, but there has been limited research to find out if topically applied CBD can decrease pain from knee osteoarthritis. CBD lacks the psychoactive effects seen with marijuana use, because it does not contain THC which is responsible for those effects in marijuana. It is legal to use CBD in the State of Tennessee (site of study). The CBD Knee Study is sponsored by the University of Tennessee Health Science Center and is a collaborative effort between doctors at UT and Campbell Clinic. In the CBD Knee Study, the investigators are examining whether topically applied CBD dissolved in Castor Oil will relieve knee pain in persons with knee osteoarthritis. Persons who take part in the study would need to come for study visits, fill out questionnaires about their health and knee pain, and would be asked to use the topical study oil on their knees. Taking part in the CBD Knee Study is voluntary.

Key Dates

Start date
Jul 1, 2026
Status verified
Apr 2026
Primary completion
Mar 20, 2028
Completion
Mar 30, 2028

Study Design

Enrollment
30 participants (estimated)
Allocation
RANDOMIZED
Intervention model
CROSSOVER
Primary purpose
TREATMENT

Arms

  • Active Comparator: CBD+Castol Oil
    250 mg CBD dissolved in 1 ml of Castor Oil to be applied topically to the knee BID
  • Placebo Comparator: Castor Oil Alone
    1 ml of Castor Oil Alone applied topically to the knee as the placebo comparator BID

Primary Outcome Measure

Knee Pain [ Time Frame: Day 1 - Baseline One Visit, Day 30 - Follow-up One Visit, Day 44 - Baseline Two Visit, and Day 74 - Follow-up Two Visit ]

Central Contacts

Locations (1)

FacilityCityStateZIPSite coordinators
University of Tennessee Health Science CenterMemphisTennessee38163
Karen C Johnson, MD, MPH (PRINCIPAL_INVESTIGATOR)
Karen Derefinko, PhD (PRINCIPAL_INVESTIGATOR)
William Mihalko, MD, PhD (SUB_INVESTIGATOR)
Phyllis Richey, PhD (SUB_INVESTIGATOR)
Fridtjof Thomas, PhD (SUB_INVESTIGATOR)

Find similar trials in Memphis, TN